Translating Ideas into Therapies 2021- Co-hosted with the British Pharmacological Society

Speakers

Dr Pinar Akcakaya
AstraZeneca
Sweden
Kelly Bachovchin
Collaborative Drug Discovery
Dr Simon Boulton
Artios Pharma/Senior Group Leader, Francis Crick Institute.
Dr Julie Brady
University of Dundee - Drug Discovery Unit
Dr Tilmann Buerckstuemmer
Aelian Biotechnology
Austria
Prof Selim Cellek
Anglia Ruskin University
Dr Katie Chapman
MSD
Dr Simon Chell
AstraZeneca
Prof Lucie Clapp
Institute of Cardiovascular Science, University College London
Dr Nadine Clemo
Apollo Therapeutics
Dr Benedict Cross
PhoreMost
Dr Scott Damrauer
University of Pennsylvania
Dr Maria Teresa Esposito
University of Roehampton
Dr Sam Groom
University of Bath
Dr Ajay Gupta
Stephen Hague
10x Genomics
Dr Olaf Hardt
Miltenyi Biotec Ltd
Prof Christian Heinis
Ecole Polytechnique Fédérale de Lausanne (EPFL)
Switzerland
Dr Roman Hillig
Nuvisan
Emma Howarth
Langton Howarth
Dr Michael Howell
The Francis Crick Institute
Miss Claire Kelly
Fishawack
Mrs Rachel Lambert-Forsyth
British Pharmacological Society
Charles Lay
University of Nottingham
Dr Paul Mercer
The Francis Crick institute
Victor Neduva
MSD
Prof Helen Philippou
University of Leeds
Steve Rees
AstraZeneca
Dr Suzanne Riches
Nexcelom Bioscience Ltd
Dr Daniel Schäfer
Miltenyi Biotec Ltd
Dr Malcolm Skingle
GSK
Dr Ian Tomlinson
Apollo Therapeutics
Dr Monique Verstegen
Erasmus MC
Netherlands
Prof Cherry Wainwright
Robert Gordon University
Prof Henning Walczak
UCL
Dr David Weinkove
Magnitude Biosciences Ltd
Dr Christina Woo
Harvard University
United States